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ABSTRACT 
Objective 
Group 3 innate lymphoid cells (ILC3s) play a pivotal role in barrier tissues such as the gut and the 
skin, two important sites of disease in spondyloarthropathy (SpA). It was investigated whether 
normal and injured human enthesis, the key target tissue in early SpA, harboured ILC3s in entheseal 
soft tissue (EST) and adjacent peri-entheseal bone (PEB).  
Methods 
Interspinous ligament and spinous process bone was collected from donors with no systemic 
inflammatory disease, enzymatically digested and immunophenotyped. The immunological profile of 
entheseal cells was examined and the transcriptional profile of sorted ILC3s was compared to those 
isolated from SpA synovial fluid. To assess the ability of entheseal tissue to produce IL-17 and IL-22 
entheseal digests were stimulated with IL-23 and IL-1β. Osteoarthritic and ruptured Achilles tissue 
was examined histologically. 
Results 
Compared to peripheral blood, human EST had a higher proportion of ILCs (p=0.008), EST and PEB 
both had a higher proportion of NKp44
+
 ILC3s (p=0.001 and p=0.043). RORγt, STAT3 and IL-23R 
transcript expression validated the entheseal ILC3 phenotype. Cytokine transcript expression was 
similar in ILC3s isolated from enthesis and SpA synovial fluid. Normal entheseal digests stimulated 
with IL-23/IL-1β upregulated IL17A transcript and histological examination of injured/damaged 
entheses showed RORγt expressing cells.  
Conclusion 
This work shows that human enthesis harbours a resident population of ILC3s, with the potential to 
participate in spondyloarthropathy pathogenesis. 
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INTRODUCTION 
There is increasing evidence that the enthesis organ and biomechanically related structures may be 
an important site for disease initiation in spondyloarthropathy (SpA) (1, 2). In animal models, 
including IL-23 and TNFα overexpression systems, primary entheseal disease results in subsequent 
spreading to the adjacent synovium and bone (1, 3).  Until recently, the enthesis with its avascular 
region of fibrocartilage at the bone interface and adjacent tendon, ligament or capsules that are 
composed of fibrocartilage and dense stromal connective tissue was not studied as an immune 
organ.  However, the seminal work of Sherlock and colleagues showed that the normal murine 
enthesis had a low abundance of immune cells that were IL-23 dependent that are nevertheless, 
critical to SpA pathogenesis (1). 
The description of a family of cytokine dependent innate lymphoid cells (ILCs), that play a pivotal 
role in barrier tissue homeostasis, repair and inflammation (4, 5) has led to major new avenues for 
inflammatory disease immunopathogenesis investigation. In recent years, the importance of ILCs in 
gut and skin, both targets of SpA in man, has been reported with a possible role for these cells in 
tissue repair and homeostasis (4, 5). Since the normal mechanically stressed human enthesis is a site 
of microdamage and miscroscopic inflammation in normal aged enthesis, it is feasible that the 
human enthesis under physiological conditions may also contain ILCs.    
In humans, ILCs can be broadly subdivided into three main categories; ILC1s which are defined by 
their ability to produce IFNγ, ILC2s that are able to produce TH2 associated cytokines and an ILC3 
subpopulation characterised by expression of the truncated retinoic acid-receptor (RAR)-related 
orphan receptor gamma (RORγt) (5). Human SpAs are genetically linked to the IL-23/17 cytokine axis 
(6) and therapeutic antagonism of this pathway is effective in SpA (6) the ability of ILC3s to respond 
to IL-β / IL-23 signalling with IL-17 and IL-22 production is especially relevant (5). Additionally, ILC3s 
are comparatively abundant in SpA related synovial fluid (7, 8) and have also been shown to be 
increased in psoriatic skin (9) and play a pivotal role in gut homeostasis and in experimental 
inflammatory bowel disease (4, 5, 7).  Given the importance of ILC3 in the skin and gut in addition to 
emerging animal model data, we hypothesised that the normal human enthesis harbours ILC3s with 
the potential for activation by local or systemic IL-23.  Herein, we describe methodology for the 
assessment of human entheseal immune populations in health and following immune stimulation 
and provide a preliminary characterisation of human group 3 ILCs. 
 
METHODS 
Enthesis samples. 
Normal inter-spinous process enthesis (n=13, median age 52, 8 male) were obtained from patients 
undergoing spinal decompression, or scoliosis correction surgery of thoracic or lumbar vertebrae. 
Unmatched peripheral blood was also collected both from patients undergoing surgery and from 
healthy controls (n=14, median age 42, 9 male). To compare normal entheseal ILC3s with those from 
active inflammatory disease, synovial fluid samples from knee synovitis in SpA were also examined 
(n=4).  
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To determine whether ILCs might be present at sites of enthesis damage, injured enthesis was 
obtained from patients undergoing surgical repair of ruptured Achilles’ tendons with tissue being 
procured from the peri-entheseal rupture site (n=3). Similarly, anterior cruciate ligament (ACL), 
which is known to be damaged by the osteoarthiric process, was obtained from patients undergoing 
knee arthroplasty for the treatment of advanced osteoarthritis (n=7).  
 
 
Digested Enthesis Immune cell cytometric evaluation.   
Since the earliest lesions in human SpA appear to occur in either the enthesis soft tissue or in sub-
fibrocartilagenous bone (10), both Entheseal soft tissue (EST) and peri-entheseal bone (PEB) was 
initially separated, see Figure 1A and digested in collagenase solution as previously described (11), 
for a detailed description see supplementary methods. Mononuclear cells were isolated using a 
density gradient medium, Lymphoprep
TM
 (Axis Shield, Dundee, UK) in all cases. T-cells, B-cells and 
natural killer cells (NK cells) were discriminated based on forward and side scatter characteristics 
and expression of CD45 then CD3, CD19 and CD56 respectively. T-cell subsets, T-helper cells and 
cytotoxic T-cells were discriminated based on expression of CD4 and CD8 respectively, T-cells that 
did not express CD4 or CD8 (CD4
neg
CD8
neg
) were also measured and γδT-cell were identified based on 
expression of T-cell receptor (TRC) γδ (Supplementary Figure 1). Entheseal ILC subsets were 
discriminated based on expression of cell surface phenotype; ILC1: Lin
-
 (CD1a, CD3, CD14, CD11c, 
CD19, CD34, CD94, CD123, CD303, FCεR1, TRCαβ, TRCγδ) CD45
+
, CD127
+
, CRTH2
-
, c-Kit
- 
. ILC2: Lin
-
, 
CD127
+
, CD45
+
, CRTH2
+
. ILC3: Lin
-
, CD45
+
, CD127
+
,
 
CRTH2
-
, c-Kit
+ 
(5, 7, 8) (Supplementary Table 1), 
dead cells were discriminated based on uptake of aqua dye (ThermoFisher, Altrincham, UK), or 7-
Amino actinomycin D (BD, Oxford, UK). An Influx (BD) fluorescence activated cell sorter was used to 
isolate entheseal ILC subsets, immunophenotyping in unsorted samples was performed on a LSR II 
flow cytometer (BD).  
 
Transcript analysis pre and post enthesesal digest cytokine stimulation.   
Analysis of key IL-23/IL-17 axis cytokine expression changes was performed on unsorted whole 
entheseal digests. Following digestion, 2x10
6
 cells were incubated at 37°C, 5% CO2 with Iscove's 
Modified Dulbecco's Medium (Gibco, Paisley, UK) containing 10% foetal calf serum (Biosera, 
Boussens, France) in the presence or absence of IL-1β (10ng/ml, Miltenyi Biotec, Bisley, UK) and IL-
23 (50ng/ml, Miltenyi), after 48 hours cells were prepared for RNA isolation. 
RNA was isolated using PicoPure RNA isolation kit (ThermoFisher), and cDNA was synthesised using a 
high capacity reverse transcription kit (ThermoFisher). Pre-amplification of target transcripts was 
performed using GE PreAmp kit (Fluidigm, San Francisco, USA), this step was omitted in cytokine 
stimulation assays. Quantitative real-time PCR was performed using an ABI7500 (Applied 
Biosystems) thermocycler to measure expression of immunomodulatory and pro-inflammatory 
transcripts. All target gene expression was calculated relative to expression of housekeeping gene 
HPRT1, values below detection were not considered or plotted unless otherwise stated. 
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 Histology and Immunofluorescence microscopy.   
For immunofluorescence microscopy, frozen sections of healthy entheseal soft tissue (EST) were 
incubated with fluorescently labelled antibodies against CD3 and RORγt (Supplementary Table 1) 
and counterstained with 4′,6-Diamidine-2′-phenylindole dihydrochloride (DAPI). 
Tissue samples from Achilles’ tendon, ACL (Figure 1B) and spinous process were prepared for 
histology using standard protocols and stained using mouse anti-human RORγt (Supplementary 
Table 1), EnVision+ horseradish staining system (Dako, Ely, UK) and counterstained with Harris 
haematoxylin.  
 
Statistics 
The Independent samples Kruskal-Wallis Test was used to detect differences between peripheral 
blood, EST and PEB samples with regards to the proportions of T-cells and cells classified as “others” 
in Figure 1C as well as CD4
neg
CD8
neg
 T-cells and γδT-cells in Figure 1D. The Wilcoxon Signed Rank Test 
was used to detect changes in gene expression in entheseal digests with or without cytokine 
stimulation. The Mann-Whitney U test was used to detect difference between groups in all other 
data sets. Significance was set at >95%, SPSS version 21 (IBM) was used to calculate all statistics, 
GraphPad Prism 6 (GraphPad Software) was used to generate all graphs. Bar charts show mean and 
standard error, box plots show median (line), interquartile range (box) and extreme values 
(whiskers). 
 
RESULTS 
Immunological profiling of entheseal tissue 
Initial assessment of the total entheseal lymphocyte content revealed significant differences in the 
proportions of T-cells between aged-matched peripheral mononuclear cells (PBMCs) and EST and 
PEB digests (p=0.018). There was also a significant difference in the percentage of cells not defined 
as T-cells, B-cells or NK-cells within these categories (p=0.016, Figure 1C). Examination of T-cell 
subsets also showed an increase in the proportion of T-cells expressing neither the CD4 or CD8 
antigen in entheseal digests compared to peripheral blood (p=0.021). Additionally, γδT-cells were 
also significantly increased in comparison to peripheral blood (p=0.027, Figure 1D).  
ILC3s defined as Lin
-
, CD45
+
, RORγt
+
, CD3
-
 were not detected in the normal enthesis using 
immunofluorescence, likely reflecting their extreme rarity in health (Supplementary Figure 2), 
necessitating a cytometric approach to ILC3 detection. Digested entheseal tissue showed the 
consistent presence of ILCs as identified by cell surface phenotype (Figure 1E) (5).  
 
ILCs detected in enthesis tissues a have distinct phenotype from those in peripheral blood 
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In order to ascertain if ILCs detected in entheseal tissues were a resident population, as distinct from 
passenger cells merely trapped in the vasculature, the frequency of all ILCs in peripheral blood was 
compared to EST and PEB digests. EST had a substantially greater proportion of ILCs (p=0.008) 
compared to unmatched peripheral blood median 0.08% (0.03-0.20%), EST: 0.54% (0.06-2.06%), 
PEB: 0.24% (0.03-0.49%, Figure 1F). The proportion of total ILCs identified as ILC3 and expressing the 
NKp44 cell surface antigen was also examined. In peripheral blood, the percentage of lymphocytes 
identified as ILC3s and expressing the NKp44 marker was 0.21% (0-1.13%) EST digests had a 
significantly greater proportion of these cells, median 5.3% (0.8-50.9%, p=0.001). These were also 
elevated in PEB digests, median 3.03% (0-13.84%, p=0.043) compared to peripheral blood 
(Figure1G). Taken together these data provide strong evidence that the ILC3 populations in EST and 
PEB tissue are entheseal resident and unlikely to originate from peri-entheseal blood vessels. In EST 
ILC3s constituted 0.25% (0.02-0.92%) of the total lymphocyte population. NKp44
-
 ILC3s constituted 
0.16% (0.01-0.17%) and those expressing the NKp44
 
marker constituted 0.09% (4.25x10
-3
-0.23%). 
Cells phenotypically identified as ILC1s constituted 0.20% (0-0.49), ILC2s 0.23% (0-1.17%) of the total 
lymphocytic fraction (Supplementary Table 2). The proportion of ILC subsets observed in PEB was 
broadly similar to EST; PEB did contain fewer ILC2s on average although this was not statistically 
significant. 
 
Confirmation of ILC3 phenotype and comparison to synovial SpA origin ILC3s 
Comparison of gene expression from ILC3s sorted from EST showed a highly significant increase in 
the expression of RORC (RORγt) transcript compared to unsorted entheseal derived mononuclear 
cells (p=0.009, Figure 2A) confirming ILC3 phenotype (5). Similar results were obtained from ILC3s 
isolated from PEB (p=0.032, Figure 2B). Since the frequency of ILC3s is known to be increased in the 
synovial fluid of patients suffering from SpA (7), comparison of immunomodulatory transcripts from 
ILC3s isolated from enthesis and SpA synovial fluid was made to further confirm ILC3 phenotype. 
Sorted ILC3 transcript analysis showed high expression of TGFβ and TNFα, both mediators with 
opposing immunomodulatory and inflammatory roles in the context of SpA respectively (12). STAT3 
was expressed in all tissues indicating potential for cytokine signal transduction but significantly 
higher level in PEB ILC3s compared to both EST and SpA synovial fluid ILC3s (p=0.048, Figure 2C). 
Expression of IL-10 in ILC3s from three of five EST was noted and two of five PEB and SpA tissues, 
The EST ILC3s had no detectable IL-17A or IL-22; however, IL-17A message was detected in ILCs in 
two of five samples from normal PEB and in one of four samples from SpA synovial fluid. IL-22 
message was detected in one sample from both PEB and SpA synovial fluid (data not shown). In 
general, transcript expression between ILC3 isolated from enthesis tissues and SpA fluid was similar, 
strengthening the proposition that these cells share common functionality. 
 
Cytokine Stimulation of Enthesis 
Examination of IL-23R expression from ILC3 isolated from either EST or PEB showed a significantly 
increased level of IL-23R transcript compared to unsorted mononuclear cells (p=0.033, Figure 2D) 
both confirming immunophenotype data and the capacity for IL-23 responsiveness in these cells. 
Transcriptional analysis of IL-1β/IL-23 cytokine stimulated entheseal digests showed a significant 
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increase (p=0.046) in expression of IL-17A (Figure 2E). Expression of IL-17F and IL-22 also showed a 
clear upward trend following stimulation although this fell short of significance (Figures 2F and 2G). 
These data provide functional support for human entheseal resident cells capable of IL-17A 
production in response to cytokine stimulation. 
 
 
Evidence for ILC3s at sites of Enthesis Injury 
Tissue from peri-entheseal regions of ruptured tendons showed inflammatory infiltrates expressing 
the RORγt protein this was observed in 2 of 3 donors (Figure 3A).  Likewise, peri-entheseal tissue 
from intact ACL from osteoarthritic donors showed cells expressing the RORγt protein in entheseal 
soft tissue in 5 of 7 donors (Figure 3B) and in the peri-entheseal bone 7 of 7 donors (Figure 3C). 
Positive staining for RORγt was also observed in areas of active bone re-modelling in OA in 5 of 7 
donors (Figure 3D). For comparison, healthy spinal tissue was also examined. Positive staining was 
absent in 6 of 7 of EST tissues (Figure 3E) as well as in control Achilles tendon (data not shown). 
Expression RORγt was observed in control PEB, harvested from spinous process (Figure 3E), and 
consistently present in cancellous bone harvested from iliac crest (data not shown).  
 
DISCUSSION  
Recently there has been a convergence of genetic, molecular and therapeutic data pointing towards 
a role for the IL-23/17 axis in the pathogenesis of the SpA group of related diseases including 
psoriasis and inflammatory bowel disease. With the expanding literature showing that group 3 ILCs 
play an important role in skin and gut homeostasis, we investigated whether ILC3s were present at 
the human enthesis a key target tissue in early SpA. The proportion of ILC3s expressing the NKp44 
marker in entheseal soft tissue and peri-entheseal bone confirms that these cells are resident 
populations of ILCs and could not entirely be made-up cells released from peripheral blood vessels.  
To confirm our phenotypic evaluation, RORγt transcript was measured in sorted ILC3s and found 
elevated RORγt transcript levels, an important ILC3 lineage transcription factor (4). The detection of 
IL-23R transcripts in ILC3 isolates gives additional confirmation of ILC3 phenotypes. Abundant TGFβ 
was found in normal enthesis ILC3s, possibly indicating an immunoregulatory phenotype in the 
absence of inflammatory signalling. However, TGFβ was also elevated in ILCs from SpA synovial fluid, 
a known inflammatory environment (7). Overall, ILC3s isolated from entheseal tissues and SpA 
synovial fluid were very similar in their expression of cytokine transcripts perhaps indicating 
comparable activation states. It should be noted that in this study transcriptional analysis was 
limited due to the low cellular yield from sorted populations. Indeed, in many cases conventional 
PCR was unable to resolve the expression levels of some genes of interest. Ultra-low cell number or 
single cell compatible techniques such as RNAseq may provide a more appropriate means of 
characterising entheseal populations in future. 
Normal whole entheseal digests were stimulated with IL-1β and IL-23 and showed a clear increase in 
IL-17 and, to a lesser extent, IL-22 transcripts. Although this work does not address the cellular origin 
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of these signals it nevertheless confirms that this relatively acellular tissue is capable of responding 
as a whole to stimulation by increasing IL-17 and IL-22 transcript production. RORγt transcription 
factor expression was found in inflammatory infiltrate of ruptured Achilles tendon tissue and in peri-
entheseal bone in OA derived enthesis.  Although it is likely that cells other than ILC3s, including 
Th17 cells, contribute a large portion of this signal this nevertheless highlights the involvement of 
the IL-23/IL-17 axis in responding to injury at the enthesis.  
The elevated proportion of NKp44
+
 ILC3s is interesting from a functional perspective since it has 
been shown that NKp44 positive but not negative ILC3s are capable of producing IL-22 (5). Given 
that IL-22 signalling has been implicated in promoting osteogenesis (13), the presence of an elevated 
proportion of NKp44
+ 
ILC3s may suggest a potential mechanism for spondyloarthropathy 
pathogenesis in respect to new bone formation.  
The present studies in man was motivated by the emerging literature on ILCs and from the IL-23 
dependent model of SpA reported by Sherlock et al (1). Recent murine model studies have shown 
that this IL-23 SpA model is association with an accumulation of γδT-cells in entheseal regions (14). 
These T-cells do not typically express CD4 or CD8 and share many similarities to ILC3s, particularly in 
their response to cytokine stimulation. Although some caution should be given to direct comparison 
between animal models and human disease, we noted that T-cells that lacked expression of CD4 and 
CD8 were elevated in entheseal digests. Further examination of T-cell subsets indicated that a high 
proportion of these cells were likely γδT-cells, further characterisation of this T-cell subset in human 
enthesis is important especially in light of the animal model data suggesting a role for γδT-cells in 
SpA pathogenesis (1, 14). 
In conclusion, this proof of concept work demonstrated that enthesis related soft tissue and peri-
entheseal bone harbours a population of resident ILC3s. The frequency of such cells as a proportion 
of CD45+ lymphocytes is marginally lower (0.25% in EST, 0.07% in PEB) than that reported in gut 
(~0.90%) (15) and skin (0.35%) (9). This lower frequency may be due to enthesis non-exposure to 
external environments compared to the skin and gut.  Further work is needed to define the exact 
micro-anatomical topography of these rare cells and to look at other entheses around the body, as 
well as to undertake studies in disease. The ability to robustly define and purify these rare cells and 
define other immune cells at the enthesopathies opens up new avenues to explore immunity in early 
SpA.   
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 FIGURE LEGENDS 
Figure 1: Lymphocyte populations in entheseal tissue.  
Schematic of the spine showing the area harvested for analysis (dotted line)(A). Photomicrograph of 
the entheseal region of the ACL stained with Haematoxylin and eosin (B). Lymphocyte populations in 
peripheral blood (PB, n=8, black bar), entheseal soft tissue (EST, n=3, white bar) and peri-entheseal 
bone (PEB, n=3, grey bar). Viable lymphocytes are classified as T-cells (CD3
+
), B-cells (CD19
+
) and NK-
cells (CD3
-
, CD56
+
) cells outside of these categories are labelled “others” (C). T-cells (from C) 
subdivided into CD4
+
 (T-helper), CD8
+
 (cytotoxic T-cells), CD4
neg
CD8
neg 
(double negative) and TCRγδ 
(γδ-Tcells) (D).  Sorting strategy and representative plot for isolation of ILC subsets, ILC are identified 
from lymphocytes based on expression of CD127 and lack of expression of CD1a, CD3, CD14, CD11c, 
CD19, CD34, CD94, CD123, CD303, FCεR1, TRCαβ, TRCγδ. ILC subtypes were then identified; ILC1: 
CRTH2
-
 c-Kit
-
, ILC2: CRTH2
+ 
c-Kit
-
, ILC3: CRTH2
-
 c-Kit
+
. ILC3s are subdivided based on expression of 
NKp44 (E). Proportion of lymphocytes identified as ILCs in PB (n=9), EST (n=7) and PEB (n=6) (F). 
Proportion of ILCs classified as ILC3s expressing the NKp44 marker in PB (n=8), EST (n=7) and PEB 
(n=6) (G). *p<0.05, **p<0.01, ***p<0.001 by Kruskal-Wallis test (C and D) and Mann-Whitney U test 
(F and G). 
Figure 2: Phenotype confirmation and cytokine stimulation  
Relative expression of RORC (RORγt) transcript in sorted ILC3 cells in comparison to unsorted 
mononuclear cells in entheseal soft tissue (n=6) (A) and peri-entheseal bone (n=5) (B). Expression of 
immunomodulatory transcripts ILC3s isolated from entheseal soft tissue (n=5, white circles), peri-
entheseal bone (n=5, grey squares) and SpA synovial fluid (n=4, black triangles), line shows mean (C). 
Expression of IL-23R transcript in unsorted mononuclear cells and ILC3s (combined from both 
entheseal soft tissue and peri-entheseal bone both n=7, four values fell below detection in ILC3s), 
line shows mean, whiskers-standard error (D). Expression of IL-17A (E), IL-17F (F) and IL-22 (G) in 
whole entheseal digests with and without stimulation by IL1β and IL-23 (all n=7). Triangles denote 
values below detection, these are given assumed values of 1x10
-5
, assumed values were also used 
for statistical comparison. All gene expression values shown are relative to HPRT1 expression, 
*p<0.05, **p<0.01, by Man-Whitney U test, box plots show median (line), interquartile range (box) 
and extreme values (whiskers). 
Figure 3: Tissue localisation in entheseal tissue. 
Immunohistochemistry photomicrographs showing RORγt protein expression in ruptured Achilles 
tendon (A), as well as in osteoarthritic anterior cruciate ligament entheseal soft tissue (B), 
osteoarthritic anterior cruciate ligament peri-entheseal bone (C) and in regions of active bone 
remodelling in osteoarthritic anterior cruciate ligament (D). RORγt was mostly absent in spinous 
process entheseal soft tissue (E) but was expressed in spinous process peri-entheseal bone (F). 
Images are 200x magnification, arrows highlight regions of positive staining.   
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Supplementary Figure 1: Gating strategy for identification of γδT-cells 
Lymphocytes were gated based on forward scatter (FSC) and side scatter (SSC) profile (A), live cells 
were then discriminated based on non-uptake of 7-Aminoactinomycin D (B). T-cells were identified 
based on expression of CD3 and CD45 (C) from these γδT-cells were identified by expression of T-cell 
receptor γδ (TCRγδ) (D). Example shown, entheseal soft tissue. 
Supplementary Figure 2: Immunofluorescence staining of normal human enthesis 
Photomicrographs of human tonsil positive control and normal human entheseal soft tissue. Control 
human tonsil, blue – nucleus, red – CD3, green RORγt at 100x magnification, inset high power image 
(A). Entheseal soft tissue 100x magnification (B and C). High powered image showing accumulation 
CD3 positive T-cells (D). 
Supplementary Table 1: Antibodies  
Table shows all study antibodies FITC:  Fluorescein, PE: Phycoerythrin, APC: Allophycocyanin, BV: 
Brilliant violet, BUV: Brilliant ultra-violate, PcP: Peridinin chlorophyll protein, AF: Alexa fluor, FC: 
Flow cytometry, IHC: Immunohistochemistry, IF: Immunofluorescence. All antibodies for FC were 
used at manufacturers recommended concentrations. 
Supplementary Table 2: ILC subpopulation frequency 
Table shows ILC subtypes expressed as a percentage of total lymphocyte cellularity in entheseal soft 
tissue (EST, n=7) and peri-entheseal bone (PEB, n=6). 
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Figure 1: Lymphocyte populations in entheseal tissue.  
Schematic of the spine showing the area harvested for analysis (dotted line)(A). Photomicrograph of the 
entheseal region of the ACL stained with Haematoxylin and eosin (B). Lymphocyte populations in peripheral 
blood (PB, n=8, black bar), entheseal soft tissue (EST, n=3, white bar) and peri-entheseal bone (PEB, n=3, 
grey bar). Viable lymphocytes are classified as T-cells (CD3+), B-cells (CD19+) and NK-cells (CD3-, CD56+) 
cells outside of these categories are labelled “others” (C). T-cells (from C) subdivided into CD4+ (T-helper), 
CD8+ (cytotoxic T-cells), CD4negCD8neg (double negative) and TCRγδ (γδ-Tcells) (D).  Sorting strategy 
and representative plot for isolation of ILC subsets, ILC are identified from lymphocytes based on expression 
of CD127 and lack of expression of CD1a, CD3, CD14, CD11c, CD19, CD34, CD94, CD123, CD303, FCεR1, 
TRCαβ, TRCγδ. ILC subtypes were then identified; ILC1: CRTH2- c-Kit-, ILC2: CRTH2+ c-Kit-, ILC3: CRTH2- 
c-Kit+. ILC3s are subdivided based on expression of NKp44 (E). Proportion of lymphocytes identified as ILCs 
in PB (n=9), EST (n=7) and PEB (n=6) (F). Proportion of ILCs classified as ILC3s expressing the NKp44 
marker in PB (n=8), EST (n=7) and PEB (n=6) (G). *p<0.05, **p<0.01, ***p<0.001 by Kruskal-Wallis test 
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(C and D) and Mann-Whitney U test (F and G).  
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Figure 2: Phenotype confirmation and cytokine stimulation  
Relative expression of RORC (RORγt) transcript in sorted ILC3 cells in comparison to unsorted mononuclear 
cells in entheseal soft tissue (n=6) (A) and peri-entheseal bone (n=5) (B). Expression of immunomodulatory 
transcripts ILC3s isolated from entheseal soft tissue (n=5, white circles), peri-entheseal bone (n=5, grey 
squares) and SpA synovial fluid (n=4, black triangles), line shows mean (C). Expression of IL-23R transcript 
in unsorted mononuclear cells and ILC3s (combined from both entheseal soft tissue and peri-entheseal bone 
both n=7, four values fell below detection in ILC3s), line shows mean, whiskers-standard error (D). 
Expression of IL-17A (E), IL-17F (F) and IL-22 (G) in whole entheseal digests with and without stimulation 
by IL1β and IL-23 (all n=7). Triangles denote values below detection, these are given assumed values of 
1x10-5, assumed values were also used for statistical comparison. All gene expression values shown are 
relative to HPRT1 expression, *p<0.05, **p<0.01, by Man-Whitney U test, box plots show median (line), 
interquartile range (box) and extreme values (whiskers).  
 
Page 14 of 19
John Wiley & Sons
Arthritis & Rheumatology
This article is protected by copyright. All rights reserved.
 
83x151mm (300 x 300 DPI)  
 
 
Page 15 of 19
John Wiley & Sons
Arthritis & Rheumatology
This article is protected by copyright. All rights reserved.
  
 
 
Figure 3: Tissue localisation in entheseal tissue.  
Immunohistochemistry photomicrographs showing RORγt protein expression in ruptured Achilles tendon (A), 
as well as in the entheseal soft tissue (B), peri-entheseal bone (C) and in regions of active bone remodelling 
in osteoarthritic anterior cruciate ligament. RORγt was mostly absent in healthy entheseal tissue (E) but was 
expressed in healthy entheseal bone (F). Images are 200x magnification, arrows highlight regions of positive 
staining.    
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